Mathews Journal of Case Reports

2474-3666

Previous Issues Volume 8, Issue 9 - 2023

Prognostic Factors of Locally Advanced Non Metastatic Rectal Cancer in Tunisia

Zouari Sirine1, Ayadi Ines2,* ,Ben Salah Hanen1, , Khmiri Souhir2 , Elloumi Fatma1, Boujelbene Salah3, Boudawara Tahia4, Ben Mahfoudh khaireddine5, Khanfir Afef2, Daoud Jamel1

1Radiotherapy Department, Habib Bourguiba Hospital, University of Sfax, Tunisia

2Medical oncology Department, Habib Bourguiba Hospital, University of Sfax, Tunisia

3Surgery Department, Habib Bourguiba Hospital, University of Sfax, Tunisia

4Anatomopathology Department, Habib Bourguiba Hospital, University of Sfax, Tunisia

5Radiology Department, Habib Bourguiba Hospital, University of Sfax, Tunisia

*Corresponding Author: Inès AYADI, Radiotherapy Department, Habib Bourguiba Hospital, University of Sfax, Tunisia; Tel: +21697266914; Email: [email protected]

Received Date: October 10, 2023

Publication Date: October 23, 2023

Citation: Sirine Z, et al. (2023). Prognostic Factors of Locally Advanced Non Metastatic Rectal Cancer in Tunisia. Mathews J Case Rep. 8(9):127.

Copyright: Sirine Z, et al. © (2023)

ABSTRACT

Introduction: Multimodal treatment based on radio chemotherapy and surgery has improved the local control rate of rectal cancer, but the metastatic relapse rate and overall survival remained stable. The purpose of our study was to analyze the prognostic factors of Overall survival (OS), event-free survival (EFS), locoregional recurrence-free (LFS) and metastasis-free survival (MFS). Patients and methods: It was a retrospective study of patients with locally advanced non-metastatic rectal cancer treated with radio-chemotherapy and surgery at Habib Bourguiba Sfax University Hospital from January 2009 to December 2017. Results: We collected 66 patients. 5-year OS and EFS were 53% and 60% respectively, and the 5-year DFS was 82%. DFS at 5 years was 73%. In multivariate analysis, the independent prognostic factors retained for OS were tumor perforation (p=0.02) peri-nervous sheathing (p=0.03) and presence of recurrence (p=0.04). Factors that significantly influenced EFS were delays in adjuvant CT beyond 8 weeks (p=0.009), presence of lymphovascular emboli (p=0.04), and invaded circumferential boundaries (p=0.03). An invaded circumferential margin was the only variable significantly influencing LFS survival in multivariate study (p = 0.02). The presence of peri-neural engorgement and lymph node invasion on anatomopathological examination of the surgical specimen were retained as pejorative prognostic factors of metastatic recurrence (p = 0.02). Conclusion: The prognosis of rectal cancers remains reserved. Accurate pre-treatment evaluation and optimization of neoadjuvant treatment according to disease prognostic factors could improve oncological outcomes. Conclusion: The prognosis of rectal cancers remains reserved. Accurate pre-treatment evaluation and optimization of neoadjuvant treatment according to disease prognostic factors could improve oncological outcomes.

Keywords: Radiotherapy, Chemotherapy, Rectal cancer


Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com